HeRO Graft is the only fully subcutaneous AV access solution clinically proven to maintain long-term access for hemodialysis patients with central venous stenosis. HeRO Graft is FDA classified as a graft.

The HeRO Graft is intended for use in maintaining long-term vascular access for chronic hemodialysis patients who have exhausted peripheral venous access sites suitable for fistulas or grafts. See the Instructions for Use manual for a step-by-step implant procedure and full prescribing information.

HeRO Graft consists of two primary components:

• A Venous Outflow Component
• An ePTFE Arterial Graft Component

The HeRO Graft Venous Outflow Component

Utilizing endovascular techniques, the Venous Outflow Component is placed in the central venous vasculature with the radiopaque distal tip in the mid to upper right atrium.

The HeRO Graft Arterial Graft Component

At the deltopectoral groove, the proprietary titanium connector on the graft is joined with the Venous Outflow Component. A standard arterial anastomosis is performed to attach the ePTFE graft to the target artery.

13-0021 Rev. F